|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Jul―03 |
NRICM101 in Combatting COVID-19 Induced Brain Fog: Neuroprotective Effects and Neurovascular Integrity Preservation in hACE2 Mice |
Cher-Chia Chang, Yea-Hwey Wang, Jiin-Cherng Yen, Chia-Ching Liaw, Keng-Chang Tsai, Wen-Chi Wei, et al. (+5) Wen-Fei Chiou, Chun-Tang Chiou, Kuo-Tong Liou, Yuh-Chiang Shen, Yi-Chang Su |
2 |
[GO] |
2024―Mai―16 |
In Vivo Evaluation of Andrographis paniculata and Boesenbergia rotunda Extract Activity Against SARS-CoV-2 Delta Variant in Golden Syrian Hamsters: Potential Herbal Alternative for COVID-19 Treatment |
Supasek Kongsomros, Tussapon Boonyarattanasoonthorn, Wallaya Phongphaew, Chaiyan Kasorndorkbua, Piyanate Sunyakumthorn, Rawiwan Im-Erbsin, et al. (+12) Luis A. Lugo-Roman, Teetat Kongratanapasert, Jiraporn Paha, Suwimon Manopwisedjaroen, Pakakrong Kwankhao, Kittitach Supannapan, Nittaya Ngamkhae, Nitipol Srimongkolpithak, Pornpun Vivithanaporn, Suradej Hongeng, Arunee Thitithanyanont, Phisit Khemawoot |
3 |
[GO] |
2024―Jan―16 |
Natural 7,8-secolignans from Schisandra sphenanthera fruit potently inhibit SARS-CoV-2 3CLpro and inflammation |
Bin Li, Liansheng Qiao, Jianuo Zhang, Qi Xiao, Jiushi Liu, Bengang Zhang, Haitao Liu |
4 |
[GO] |
2022―Feb―08 |
Natural products as a source of novel drugs for treating SARS-CoV2 infection |
Ciro Isidoro, Ashley Chiung-Fang Chang, Lee-Yan Sheen |
5 |
[GO] |
2022―Jan―11 |
Role of herbal medicines in the management of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials |
Ansul Kumar, Arpita Rai, Mohd Saif Khan, Amit Kumar, Zeyaul Haque, Mohammad Fazil, Gulam Rabbani |
6 |
[GO] |
2021―Dez―13 |
Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamic simulations |
Seshu Vardhan, Suban K. Sahoo |
7 |
[GO] |
2021―Okt―16 |
Targeting autophagy with natural products to prevent SARS-CoV-2 infection |
Chiara Vidoni, Andréa Fuzimoto, Alessandra Ferraresi, Ciro Isidoro |
8 |
[GO] |
2021―Sep―16 |
Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection |
Takashi Tanikawa, Tsuyoshi Hayashi, Ryuichiro Suzuki, Masashi Kitamura, Yutaka Inoue |
9 |
[GO] |
2021―Sep―16 |
Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay |
Guan-Yu Chen, Yi-Cheng Pan, Tung-Ying Wu, Tsung-You Yao, Wei-Jan Wang, Wan-Jou Shen, et al. (+7) Azaj Ahmed, Shu-Ting Chan, Chih-Hsin Tang, Wei-Chien Huang, Mien-Chie Hung, Juan-Cheng Yang, Yang-Chang Wu |
10 |
[GO] |
2021―Sep―08 |
The dual role of phytochemicals on SARS-CoV-2 inhibition by targeting host and viral proteins |
Prakrity Singh, Shweta Singh Chauhan, Shraddha Pandit, Meetali Sinha, Shristee Gupta, Anshika Gupta, Ramakrishnan Parthasarathi |
11 |
[GO] |
2021―Jun―03 |
In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors |
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Rituraj Purohit, Sanjay Kumar |
12 |
[GO] |
2021―Mai―17 |
Calendulaglycoside A Showing Potential Activity Against SARS-CoV-2 Main Protease: Molecular Docking, Molecular Dynamics, and SAR Studies |
Ahmed A. Zaki, Ahmed Ashour, Sameh S. Elhady, Khaled M. Darwish, Ahmed A. Al-Karmalawy |
13 |
[GO] |
2021―Apr―14 |
Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells |
Seshu Vardhan, Suban K. Sahoo |
14 |
[GO] |
2021―Jan―22 |
Molecular Docking Analysis of Rutin Reveals Possible Inhibition of SARS-CoV-2 Vital Proteins |
Fazlur Rahman, Shams Tabrez, Rahat Ali, Ali S. Alqahtani, Mohammad Z. Ahmed, Abdur Rub |
15 |
[GO] |
2021―Jan―19 |
Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods |
Yi-Wei Zhu, Xiao-Feng Yan, Ting-Jie Ye, Jing Hu, Xiao-Ling Wang, Feng-Jun Qiu, et al. (+2) Cheng-Hai Liu, Xu-Dong Hu |
16 |
[GO] |
2021―Jan―04 |
Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: an in silico approach |
Panthakarn Rangsinth, Chanin Sillapachaiyaporn, Sunita Nilkhet, Tewin Tencomnao, Alison T. Ung, Siriporn Chuchawankul |
17 |
[GO] |
2020―Dez―29 |
Anti-COVID-19 drug candidates: a review on potential biological activities of natural products in the management of new coronavirus infection |
Anchalee Prasansuklab, Atsadang Theerasri, Panthakarn Rangsinth, Chanin Sillapachaiyaporn, Siriporn Chuchawankul, Tewin Tencomnao |
18 |
[GO] |
2020―Mai―30 |
The antiviral and the coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? |
Andréa D. Fuzimoto, Ciro Isidoro |
19 |
[GO] |
2020―Mai―30 |
Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective |
Suraphan Panyod, Chi-Tang Ho, Lee-Yan Sheen |